Plasma citrulline as a quantitative biomarker of HIV-associated villous atrophy in a tropical enteropathy population

Clinical Nutrition

Volumn 29, Issue 6, 2010, Pages 795-800

  Papadia, Cinzia ^a,b   Kelly, Paul ^c,d   Caini, Saverio ^e   Roberto Corazza, Gino ^f   Shawa, Tamara ^c,d   Franzè, Angelo ^b   Forbes, Alastair ^a   Di Sabatino, Antonio ^f  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PARMA   (Italy)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF ZAMBIA   (Zambia)

^e Istituto per lo Studio e la Prevenzione Oncologica   (Italy)

^f UNIVERSITY OF PAVIA   (Italy)

Author keywords

Biomarker; Celiac; Citrulline; HIV; Sprue; Tropical enteropathy

Indexed keywords

CITRULLINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DISEASE MARKER; ENTEROPATHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTESTINE ABSORPTION; INTESTINE CELL; INTESTINE CRYPT; INTESTINE VILLUS ATROPHY; JEJUNUM BIOPSY; MALE; QUANTITATIVE ANALYSIS; SCORING SYSTEM; TISSUE STRUCTURE; TROPICAL ENTEROPATHY;

ADULT; ATROPHY; BIOLOGICAL MARKERS; CITRULLINE; ENTEROCYTES; FEMALE; HIV; HIV INFECTIONS; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MIDDLE AGED; SPRUE, TROPICAL;

EID: 78649847889     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2010.04.008     Document Type: Article

References (40)

1. Cook G.C., Segal I., Farthing M.J. 'Tropical sprue': some early investigators favoured an infective cause, but was a coccidian protozoan involved?. Gut 1996, 39:428-429.
2. Veitch A.M., Kelly P., Zulu I.S., et al. Tropical enteropathy: a T-cell mediated crypt hyperplastic enteropathy. Eur J Gastroenterol Hepatol 2001, 13:1175-1181.
3. Keusch G.T. Subclinical malabsorption in Thailand. I. Intestinal absorption in Thai children. Am J Clin Nutr 1972, 25:1062-1066.
4. Lindenbaum J., Alam A.K., Kent T.H. Subclinical small-intestinal disease in East Pakistan. BMJ 1966, 2:1616-1619.
5. Ukabam S.O., Homeida M.M., Cooper B.T. Small intestinal permeability in normal Sudanese subjects: evidence of tropical enteropathy. Trop Med Hyg 1986, 80:204-207.
6. Iqbal T.H., Lewis K.O., Gearty J.C., Cooper B.T. Small intestinal permeability to mannitol and lactulose in the three ethnic groups resident in west Birmingham. Gut 1996, 39:199-203.
7. Kelly P., Menzies I., Crane R., Zulu I., Nickols C., Feakins R., et al. Responses of small intestinal architecture and function over time to environmental factors in a tropical population. Am J Trop Med Hyg 2004, 70:412-419.
8. Pappas P.A., Saudubray J.M., Tzakis A.G., Rabier D., Carreno M.Y., Gomez-Marin O., et al. Serum citrulline and rejection in small bowel transplantation: a preliminary report. Transplantation 2001, 72:1212-1216.
9. Pappas P.A., Saudubray J.M., Tzakis A.G., Rabier D., Carreno M.Y., Gomez-Marin O., et al. Serum citrulline as a marker of acute cellular rejection for intestinal transplantation. Transpl Proc 2002, 34:915-917.
10. Crenn P., Vahedi K., Lavergne-Slove A., Cynober L., Matuchansky C., Messing B. Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 2003, 124:1210-1219.
11. Crenn P., de Truchis P., Neveux N., Galpérine T., Cynober L., Melchior J.C. Plasma citrulline is a biomarker of enterocyte mass and an indicator of parenteral nutrition in HIV-infected patients. Am J Clin Nutr 2009, 90:1-8.
12. Hozjasz K.K., Szaflarska-Poplawska A., Oltarzewski M., Mazur J., Müller L., Jab3oñska E., Milanowski A. Whole blood citrulline levels in patients with coeliac disease. Pol Merkur Lekarski 2006, 20:173-175.
13. Gondolesi G., Ghirardo S., Raymond K., Hoppenhauer L., Surillo D., Rumbo C., et al. The value of plasma citrulline to predict mucosal injury in intestinal allografts. Am J Transpl 2006, 6:2786-2790.
14. Lutgens L., Lambin P. Biomarkers for radiation induced small bowel epithelial damage: an emerging role for plasma Citrulline. World J Gastroenterol 2007, 13:3033-3042.
15. Papadia C., Sherwood R.A., Kalantzis C., Wallis K., Volta U., Fiorini E., et al. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation. Am J Gastroenterol 2007, 102:1474-1482.
16. Luo M., Fernandez-Estivariz C., Manatunga A.K., Bazargan N., Gu L.H., Jones D.P., et al. Are plasma citrulline and glutamine biomarkers of intestinal absorptive function in patients with short bowel syndrome?. J Parenter Enteral Nutr 2007, 31:1-7.
17. Peters J.H., Wierdsma N.J., Teerlink T., van Leeuwen P.A., Mulder C.J., van Bodegraven A.A. Poor diagnostic accuracy of a single fasting plasma citrulline concentration to assess intestinal energy absorption capacity. Am J Gastroenterol 2007, 102:2814-2819.
18. Miceli E., Poggi N., Missanelli A., Bianchi P., Moratti R., Corazza G.R. Is serum citrulline measurement clinically useful in coeliac disease?. Intern Emerg Med 2008, 3:233-236.
19. Kelly P., Davies S.E., Mandanda B., Veitch A., McPhail G., Zulu I. Enteropathy in Zambians with HIV related diarrhoea: regression modelling of potential determinants of mucosal damage. Gut 1997, 41:811-816.
20. Klipstein F.A., Beauchamp I., Corcino J.J., Maldonado M., Tomasini J.T., Maldonado N., et al. Nutritional status and intestinal function among rural populations of the West Indies. Gastroenterology 1972, 63:758-767.
21. Vandgama J.V., Evered D.F. Characteristic of L-citrulline transport across rat small intestine in vitro. Pediatr Res 1992, 32:472-478.
22. Bahri S., Curis E., Aussel C., Chaumeil J., Cynober L., Zerrouk N. Caractérisation in vitro du transport intestinal de la citrulline. Nutr Clin Metab 2006, 20:S111-S112.
23. Wu G., Morris S.M. Arginine metabolism: nitric oxide and beyond. Biochem J 1998, 336:1-17.
24. Crenn P., Coudray-Lucas C., Thuillier F., Cynober L., Messing B. Postabsorptive plasma citrulline concentrations as a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000, 119:1496-1505.
25. Wakabayashi Y., Yamada E., Yoshida T., Takahashi H. Arginine becomes an essential aminoacid after massive resection of rat small intestine. J Biol Chem 1994, 269:32667-32671.
26. Osowska S., Moinard C., Neveux N., Loi C., Cynober L. Citrulline increases arginine pools and restores nitrogen balance after massive intestinal resection. Gut 2004, 53:1781-1786.
27. Miller A.R., Griffin G.E., Batman P., Farquar C., Forster S.M., Pinching A.J., Harris J.R. Jejunal mucosal architecture and fat absorption in male omosexuals infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Q J Med. 1988, 69:1009-1019.
28. Ullrich R., Heise W., Bergs C., L'age M., Höffken G., Riecken E.O. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV) infected patients. Digestion 1989, 46:302-307.
29. Ullrich R., Zeitz M., Heise W., L'age M., Ziegler K., Bergs C., Riecken E.O. Mucosal atrophy is associated with loss of activated T cells in the duodenal mucosa of human immunodeficiency virus (HIV) infected patients. Digestion 1990, 46:302-307.
30. Ullrich R., Heise W., Bergs C., L'age M., Riecken E.O., Zeitz M. Effects of zidovudine treatment on the small intestinal mucosa in patients infected with the human immunodeficiency virus. Gastroenterology 1992, 102:1483-1492.
31. Sankaran S., George M., Reay E., Guadalupe M., Flamm J., Prindiville T., Dandekar S. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol 2008, 82:538-545.
32. Epple H.J., Schneider T., Troeger H., Kunkel D., Allers K., Moos V., et al. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut 2009, 58:220-227.
33. Dworkin B., Wormser G.P., Rosenthal W.S., Heier S.K., Braunstein M., Weiss L., et al. Gastrointestinal manifestation of the acquired immunodeficiency syndrome; a review of 22 cases. Am J Gastroenterol 1985, 80:774-778.
34. Sewankambo N., Mugerwa R.D., Goodgame R., Carswell J.W., Moody A., Lloyd G., Lucas S.B. Enteropathic AIDS in Uganda. An endoscopic, histological and microbiological study. AIDS 1987, 1:9-13.
35. Fleming S.C., Kapembwa M.S., MacDonald T.T., Griffin G.E., et al. Direct in vitro infection of human intestine with HIV-1. AIDS 1992, 6:1099-1104.
36. Batman P.A., Fleming S.C., Sedgwick P.M., MacDonald T.T., Griffin G.E. HIV infection of human fetal intestinal explant cultures induces epithelial cell proliferation. AIDS 1994, 8:161-167.
37. Kotler D.P., Reka S., Chow K., Orenstein J.M. Effect of enteric parasitoses and HIV infection upon small intestinal structure and function in patients with AIDS. J Clin Gastroenterol 1993, 16:10-15.
38. Veazey R.S., Marx P.A., Lackner A.A. The mucosal immune system: primary target for HIV infection and AIDS. Trend Immunol 2001, 11:626-633.
39. Reka S., Borchich A., Cronin W., Kotler D. Diarrhoea associated with intestinal HIV infection in ARC. Clin Res 1989, 37:A371.
40. Veitch A.M., Higgins L.M., Bajaj-Elliot M., Farthing M.J., MacDonald T.T. Impaired rejection and mucosal injury of small intestinal allograft lacking the interferon-γ receptor. Int J Exp Path 2003, 84:107-113.